Spatial Domain
Spatial Domain (Tier 1)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__178_B4,8 | Lung | Primary cancer | 4,974 | Tumor/Malignant | 53.7% | 0.98 | 0.07 |
| NSCLC_38242124__IMC__178_B4,9 | Lung | Primary cancer | 2,374 | Immune | 27.4% | 0.84 | 0.43 |
| NSCLC_38242124__IMC__178_B5,1 | Lung | Primary cancer | 4,529 | Other | 73.6% | 0.98 | 0.08 |
| NSCLC_38242124__IMC__178_B5,10 | Lung | Primary cancer | 2,365 | Tumor/Malignant | 36.3% | 0.80 | 0.54 |
| NSCLC_38242124__IMC__178_B5,11 | Lung | Primary cancer | 3,810 | Tumor/Malignant | 92.8% | 0.99 | 0.02 |
| NSCLC_38242124__IMC__178_B5,12 | Lung | Primary cancer | 1,733 | Tumor/Malignant | 43.7% | 0.98 | 0.08 |
| NSCLC_38242124__IMC__178_B5,13 | Lung | Primary cancer | 2,241 | Tumor/Malignant | 68.7% | 1.00 | 0.03 |
| NSCLC_38242124__IMC__178_B5,14 | Lung | Primary cancer | 2,129 | Stromal | 35.5% | 0.89 | 0.29 |
| NSCLC_38242124__IMC__178_B5,15 | Lung | Primary cancer | 4,572 | Immune | 62.5% | 0.93 | 0.20 |
| NSCLC_38242124__IMC__178_B5,16 | Lung | Primary cancer | 3,049 | Tumor/Malignant | 47.4% | 0.93 | 0.26 |
| NSCLC_38242124__IMC__178_B5,17 | Lung | Primary cancer | 2,293 | Tumor/Malignant | 28.3% | 0.91 | 0.25 |
| NSCLC_38242124__IMC__178_B5,18 | Lung | Primary cancer | 3,090 | Tumor/Malignant | 68.3% | 0.99 | 0.05 |
| NSCLC_38242124__IMC__178_B5,2 | Lung | Primary cancer | 3,944 | Stromal | 25.3% | 0.69 | 0.73 |
| NSCLC_38242124__IMC__178_B5,4 | Lung | Primary cancer | 1,629 | Stromal | 32.5% | 0.85 | 0.43 |
| NSCLC_38242124__IMC__178_B5,5 | Lung | Primary cancer | 1,168 | Stromal | 31.4% | 0.45 | 0.92 |
| NSCLC_38242124__IMC__178_B5,6 | Lung | Primary cancer | 669 | Tumor/Malignant | 66.4% | 0.98 | 0.07 |
| NSCLC_38242124__IMC__178_B5,9 | Lung | Primary cancer | 3,839 | Immune | 30.3% | 0.47 | 0.75 |
| NSCLC_38242124__IMC__178_B6,10 | Lung | Primary cancer | 1,740 | Tumor/Malignant | 57.4% | 0.90 | 0.28 |
| NSCLC_38242124__IMC__178_B6,12 | Lung | Primary cancer | 3,828 | Immune | 44.6% | 0.93 | 0.19 |
| NSCLC_38242124__IMC__178_B6,13 | Lung | Primary cancer | 3,390 | Stromal | 34.8% | 0.52 | 0.81 |
Spatial Domain (Tier 2)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__178_B4,8 | Lung | Primary cancer | 4,974 | Tumor/Malignant | 46.0% | 0.99 | 0.03 |
| NSCLC_38242124__IMC__178_B4,9 | Lung | Primary cancer | 2,374 | Tumor/Malignant | 23.3% | 0.87 | 0.44 |
| NSCLC_38242124__IMC__178_B5,1 | Lung | Primary cancer | 4,529 | Other | 68.9% | 0.99 | 0.06 |
| NSCLC_38242124__IMC__178_B5,10 | Lung | Primary cancer | 2,365 | Tumor/Malignant | 50.7% | 0.96 | 0.20 |
| NSCLC_38242124__IMC__178_B5,11 | Lung | Primary cancer | 3,810 | Tumor/Malignant | 70.6% | 1.00 | 0.01 |
| NSCLC_38242124__IMC__178_B5,12 | Lung | Primary cancer | 1,733 | Tumor/Malignant | 38.4% | 0.96 | 0.16 |
| NSCLC_38242124__IMC__178_B5,13 | Lung | Primary cancer | 2,241 | Tumor/Malignant | 69.6% | 0.99 | 0.03 |
| NSCLC_38242124__IMC__178_B5,14 | Lung | Primary cancer | 2,129 | Tumor/Malignant | 24.4% | 0.86 | 0.36 |
| NSCLC_38242124__IMC__178_B5,15 | Lung | Primary cancer | 4,572 | Myeloid | 40.6% | 0.99 | 0.08 |
| NSCLC_38242124__IMC__178_B5,16 | Lung | Primary cancer | 3,049 | Tumor/Malignant | 39.9% | 0.96 | 0.19 |
| NSCLC_38242124__IMC__178_B5,17 | Lung | Primary cancer | 2,293 | Tumor/Malignant | 27.6% | 0.93 | 0.24 |
| NSCLC_38242124__IMC__178_B5,18 | Lung | Primary cancer | 3,090 | Tumor/Malignant | 68.7% | 0.99 | 0.06 |
| NSCLC_38242124__IMC__178_B5,2 | Lung | Primary cancer | 3,944 | Stromal | 24.7% | 0.31 | 1.08 |
| NSCLC_38242124__IMC__178_B5,4 | Lung | Primary cancer | 1,629 | Stromal | 33.4% | 0.85 | 0.45 |
| NSCLC_38242124__IMC__178_B5,5 | Lung | Primary cancer | 1,168 | Stromal | 22.3% | 0.51 | 0.89 |
| NSCLC_38242124__IMC__178_B5,6 | Lung | Primary cancer | 669 | Tumor/Malignant | 66.4% | 0.98 | 0.07 |
| NSCLC_38242124__IMC__178_B5,9 | Lung | Primary cancer | 3,839 | Stromal | 27.9% | 0.83 | 0.46 |
| NSCLC_38242124__IMC__178_B6,10 | Lung | Primary cancer | 1,740 | Tumor/Malignant | 55.6% | 0.91 | 0.27 |
| NSCLC_38242124__IMC__178_B6,12 | Lung | Primary cancer | 3,828 | Lymphoid | 26.6% | 0.73 | 0.62 |
| NSCLC_38242124__IMC__178_B6,13 | Lung | Primary cancer | 3,390 | Stromal | 29.3% | 0.86 | 0.36 |
Spatial Domain (Tier 3)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__178_B4,8 | Lung | Primary cancer | 4,974 | Tumor/Malignant cell | 53.9% | 0.97 | 0.08 |
| NSCLC_38242124__IMC__178_B4,9 | Lung | Primary cancer | 2,374 | Myeloid cell, unspecified | 26.6% | 0.77 | 0.61 |
| NSCLC_38242124__IMC__178_B5,1 | Lung | Primary cancer | 4,529 | Other | 70.6% | 0.98 | 0.06 |
| NSCLC_38242124__IMC__178_B5,10 | Lung | Primary cancer | 2,365 | Tumor/Malignant cell | 60.3% | 0.93 | 0.25 |
| NSCLC_38242124__IMC__178_B5,11 | Lung | Primary cancer | 3,810 | Tumor/Malignant cell | 92.8% | 0.99 | 0.02 |
| NSCLC_38242124__IMC__178_B5,12 | Lung | Primary cancer | 1,733 | Tumor/Malignant cell | 55.7% | 0.94 | 0.19 |
| NSCLC_38242124__IMC__178_B5,13 | Lung | Primary cancer | 2,241 | Tumor/Malignant cell | 78.8% | 0.97 | 0.09 |
| NSCLC_38242124__IMC__178_B5,14 | Lung | Primary cancer | 2,129 | Fibroblast | 33.7% | 0.89 | 0.30 |
| NSCLC_38242124__IMC__178_B5,15 | Lung | Primary cancer | 4,572 | Granulocyte | 62.8% | 0.93 | 0.20 |
| NSCLC_38242124__IMC__178_B5,16 | Lung | Primary cancer | 3,049 | Tumor/Malignant cell | 44.4% | 0.94 | 0.24 |
| NSCLC_38242124__IMC__178_B5,17 | Lung | Primary cancer | 2,293 | Tumor/Malignant cell | 28.6% | 0.92 | 0.27 |
| NSCLC_38242124__IMC__178_B5,18 | Lung | Primary cancer | 3,090 | Tumor/Malignant cell | 68.0% | 0.99 | 0.05 |
| NSCLC_38242124__IMC__178_B5,2 | Lung | Primary cancer | 3,944 | Fibroblast | 26.2% | 0.44 | 1.04 |
| NSCLC_38242124__IMC__178_B5,4 | Lung | Primary cancer | 1,629 | Fibroblast | 31.3% | 0.82 | 0.49 |
| NSCLC_38242124__IMC__178_B5,5 | Lung | Primary cancer | 1,168 | Fibroblast | 32.0% | 0.37 | 1.01 |
| NSCLC_38242124__IMC__178_B5,6 | Lung | Primary cancer | 669 | Tumor/Malignant cell | 68.9% | 0.98 | 0.09 |
| NSCLC_38242124__IMC__178_B5,9 | Lung | Primary cancer | 3,839 | Fibroblast | 28.0% | 0.75 | 0.61 |
| NSCLC_38242124__IMC__178_B6,10 | Lung | Primary cancer | 1,740 | Tumor/Malignant cell | 60.5% | 0.89 | 0.31 |
| NSCLC_38242124__IMC__178_B6,12 | Lung | Primary cancer | 3,828 | T cell | 44.3% | 0.59 | 0.70 |
| NSCLC_38242124__IMC__178_B6,13 | Lung | Primary cancer | 3,390 | Fibroblast | 37.0% | 0.80 | 0.53 |